Information collection and dissemination with respect to grant recipients

21 U.S.C. § 1533

• Title: 21 — Food and Drugs
• Chapter: SUBCHAPTER II—DRUG-FREE COMMUNITIES
• Part: A

Text

(a) Coalition information
For the purpose of audit and examination, the Administrator—
(A) shall have access to any books, documents, papers, and records that are pertinent to any grant or grant renewal request under this subchapter; and
(B) may periodically request information from a grant recipient to ensure that the grant recipient meets the applicable criteria under section 1532(a) of this title.
The Administrator shall issue a request for proposal regarding, with respect to the grants awarded under section 1532 of this title, the application process, grant renewal, and suspension or withholding of renewal grants. Each application under this paragraph shall be in writing and shall be subject to review by the Administrator.
The Administrator shall, to the maximum extent practicable and in a manner consistent with applicable law, minimize reporting requirements by a grant recipient and expedite any application for a renewal grant made under this part.
(b) Data collection and dissemination
The Administrator may collect data from—
(A) national substance use and misuse organizations that work with eligible coalitions, community anti-drug coalitions, departments or agencies of the Federal Government, or State or local governments and the governing bodies of Indian tribes; and
(B) any other entity or organization that carries out activities that relate to the purposes of the Program.
The Administrator may—
(A) evaluate the utility of specific initiatives relating to the purposes of the Program;
(B) conduct an evaluation of the Program; and
(C) disseminate information described in this subsection to—
(i) eligible coalitions and other substance use and misuse organizations; and
(ii) the general public.
The Administrator shall carry out activities under this subsection in consultation with the Advisory Commission and the National Community Antidrug Coalition Institute.
Amounts for activities under paragraph (2)(B) may not be derived from amounts under section 1524(a) of this title except for amounts that are available under section 1524(b) of this title for administrative costs.

History

(Pub. L. 100–690, title I, §1033, as added Pub. L. 105–20, §2(a)(2), June 27, 1997, 111 Stat. 230; amended Pub. L. 107–82, §1(e), (f), Dec. 14, 2001, 115 Stat. 818; Pub. L. 115–271, title VIII, §8203(b)(4)(A), Oct. 24, 2018, 132 Stat. 4111; Pub. L. 116–74, §2(c)(1)(A)(ii)(II), Nov. 27, 2019, 133 Stat. 1157.)

Editorial Notes

Editorial Notes

Amendments
2019—Pub. L. 116–74, §2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, §8203(b)(4)(A). See 2018 Amendment note below.
2018—Subsec. (b)(1)(A), (2)(C)(i). Pub. L. 115–271, §8203(b)(4)(A), as amended by Pub. L. 116–74, §2(c)(1)(A)(ii)(II), substituted "substance use and misuse" for "substance abuse".
2001—Subsec. (b)(3). Pub. L. 107–82, §1(e), added par. (3).
Subsec. (b)(4). Pub. L. 107–82, §1(f), added par. (4).

Statutory Notes and Related Subsidiaries

Effective Date of 2019 Amendment
Amendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.